Both in Biotechnology
CG Oncology vs Scholar Rock Holding
Over the past year CGON returned +80.5% and SRRK returned +24.5%; their daily moves had a correlation of 0.40.
CGON +80.5% SRRK +24.5%Growth of $1, one year, split-adjusted
| Metric | CGON | SRRK |
|---|---|---|
| Price | $70.52 | $47.75 |
| Market cap | $6.25B | $5.82B |
| Today | +1.31% | −2.81% |
| 1 month | −5.1% | −17.4% |
| 6 months | +10.3% | +10.8% |
| Year to date | +69.8% | +8.4% |
| 1 year | +87.9% | +23.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | −239.2% | — |
| Net margin | −6832.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 1,003.7× | — |
| Net cash | $1.03B | $295.9M |
| Dividend yield | — | — |
| Volatility (60d) | 46.5% | 48.2% |
| Short % of float | 16.4% | 18.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).